fludarabine has been researched along with Experimental Leukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avramis, VI; Plunkett, W | 2 |
| Gandhi, V; Huang, P; Plunkett, W | 1 |
1 review(s) available for fludarabine and Experimental Leukemia
| Article | Year |
|---|---|
Fludarabine inhibits DNA replication: a rationale for its use in the treatment of acute leukemias.
Topics: Acute Disease; Animals; Antineoplastic Agents; DNA Replication; Humans; Leukemia; Leukemia, Experimental; Mice; Vidarabine | 1994 |
2 other study(ies) available for fludarabine and Experimental Leukemia
| Article | Year |
|---|---|
2-fluoro-ATP: a toxic metabolite of 9-beta-D-arabinosyl-2-fluoroadenine.
Topics: Adenine; Adenosine Triphosphate; Animals; Arabinonucleotides; Cell Line; Chromatography, High Pressure Liquid; Leukemia P388; Leukemia, Experimental; Mice; Vidarabine | 1983 |
Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
Topics: Animals; Bone Marrow; Female; Intestinal Mucosa; Kinetics; Leukemia P388; Leukemia, Experimental; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Vidarabine | 1982 |